Harrow Health Inc

NASDAQ:HROW  
10.16
-0.05 (-0.49%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)274.94M
Current PEN/A
Forward PE N/A
2yr Forward PE 20.73
See more stats
Estimates Current Quarter
Revenue$19.35 Million
Adjusted EPS-$0.03
See more estimates
10-Day MA$10.65
50-Day MA$10.17
200-Day MA$8.94
See more pivots

Harrow Health Inc Stock, NASDAQ:HROW

102 Woodmont Boulevard, Suite 610, Nashville, Tennessee 37205
United States of America
Phone: +1.615.733.4730
Number of Employees: 125

Description

Harrow Health, Inc. engages in the development, production, and sale of innovative medications. It operates through the Pharmaceutical Compounding and Pharmaceutical Drug Development segments. The Pharmaceutical Compounding segment focuses on the operations of ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer in January 2006 and is headquartered in Nashville, TN.